Elisabeth A. Berg

807 total citations
9 papers, 604 citations indexed

About

Elisabeth A. Berg is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Elisabeth A. Berg has authored 9 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology and Allergy. Recurrent topics in Elisabeth A. Berg's work include Vasculitis and related conditions (5 papers), Cell Adhesion Molecules Research (5 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Elisabeth A. Berg is often cited by papers focused on Vasculitis and related conditions (5 papers), Cell Adhesion Molecules Research (5 papers) and Atherosclerosis and Cardiovascular Diseases (3 papers). Elisabeth A. Berg collaborates with scholars based in United States, Netherlands and Australia. Elisabeth A. Berg's co-authors include Susan L. Hogan, Yichun Hu, Ronald J. Falk, J. Charles Jennette, Gloria A. Preston, Donna O. Bunch, Patrick H. Nachman, Caroline J. Poulton, Madelyn Burkart and Jiajin Yang and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Journal of the American Society of Nephrology.

In The Last Decade

Elisabeth A. Berg

9 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth A. Berg United States 7 474 289 187 120 115 9 604
Daina Selga Sweden 12 386 0.8× 106 0.4× 134 0.7× 98 0.8× 136 1.2× 18 458
Jan Willem Cohen Tervaert Netherlands 7 395 0.8× 188 0.7× 142 0.8× 61 0.5× 116 1.0× 8 467
Maria Weiner Sweden 10 301 0.6× 85 0.3× 101 0.5× 99 0.8× 95 0.8× 19 391
K.J.M. Assmann Netherlands 10 92 0.2× 194 0.7× 195 1.0× 70 0.6× 22 0.2× 12 448
Jane Hollis United Kingdom 4 87 0.2× 154 0.5× 88 0.5× 58 0.5× 20 0.2× 6 301
R. H. C. Brons Netherlands 6 130 0.3× 106 0.4× 39 0.2× 73 0.6× 85 0.7× 7 317
Francisco Díaz‐Crespo Spain 10 126 0.3× 59 0.2× 46 0.2× 73 0.6× 80 0.7× 37 268
Vesna Júrčić Slovenia 7 202 0.4× 39 0.1× 130 0.7× 27 0.2× 33 0.3× 28 265
Jeanne Pistillo United States 6 76 0.2× 150 0.5× 27 0.1× 27 0.2× 88 0.8× 12 571
Boaz Palterer Italy 12 49 0.1× 111 0.4× 157 0.8× 46 0.4× 28 0.2× 33 362

Countries citing papers authored by Elisabeth A. Berg

Since Specialization
Citations

This map shows the geographic impact of Elisabeth A. Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth A. Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth A. Berg more than expected).

Fields of papers citing papers by Elisabeth A. Berg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth A. Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth A. Berg. The network helps show where Elisabeth A. Berg may publish in the future.

Co-authorship network of co-authors of Elisabeth A. Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth A. Berg. A scholar is included among the top collaborators of Elisabeth A. Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth A. Berg. Elisabeth A. Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Roth, Aleeza J., Joshua D. Ooi, Mirjan M. van Timmeren, et al.. (2013). Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. Journal of Clinical Investigation. 123(4). 1773–1783. 184 indexed citations
2.
Free, Meghan E., Donna O. Bunch, J. Mcgregor, et al.. (2013). ANCA disease patients have defective Treg function exacerbated by expansion of a suppression-resistant effector population. La Presse Médicale. 42(4). 656–656. 1 indexed citations
3.
Bunch, Donna O., Madelyn Burkart, Yichun Hu, et al.. (2013). Decreased CD5+ B Cells in Active ANCA Vasculitis and Relapse after Rituximab. Clinical Journal of the American Society of Nephrology. 8(3). 382–391. 82 indexed citations
4.
Free, Meghan E., Donna O. Bunch, J. Mcgregor, et al.. (2013). Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Have Defective Treg Cell Function Exacerbated by the Presence of a Suppression‐Resistant Effector Cell Population. Arthritis & Rheumatism. 65(7). 1922–1933. 124 indexed citations
5.
Berg, Elisabeth A., et al.. (2013). What everybody is doing but no one is talking about: Complementary and alternative medicine (CAM) prevalence in the ANCA SVV population. La Presse Médicale. 42(4). 775–775. 1 indexed citations
6.
Yang, Jiajin, Susan L. Hogan, Yichun Hu, et al.. (2012). High Basal Activity of the PTPN22 Gain-of-Function Variant Blunts Leukocyte Responsiveness Negatively Affecting IL-10 Production in ANCA Vasculitis. PLoS ONE. 7(8). e42783–e42783. 34 indexed citations
7.
Roth, Aleeza J., Michael C. Brown, R. Neal Smith, et al.. (2011). Anti–LAMP-2 Antibodies Are Not Prevalent in Patients With Antineutrophil Cytoplasmic Autoantibody Glomerulonephritis. Journal of the American Society of Nephrology. 23(3). 545–555. 92 indexed citations
8.
Schmitz, John L., Jiajin Yang, Susan L. Hogan, et al.. (2011). DRB1*15 Allele Is a Risk Factor for PR3-ANCA Disease in African Americans. Journal of the American Society of Nephrology. 22(6). 1161–1167. 79 indexed citations
9.
Bommel, Eric F.H. van, Lambertus J.H. van Tits, Elisabeth A. Berg, J. A. Prins, & Anton F. H. Stalenhoef. (2009). Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case–control study. Rheumatology International. 31(2). 201–208. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daina Selga Breakdown of academic impact, for papers by Jan Willem Cohen Tervaert Breakdown of academic impact, for papers by Maria Weiner Breakdown of academic impact, for papers by K.J.M. Assmann Breakdown of academic impact, for papers by Jane Hollis Breakdown of academic impact, for papers by R. H. C. Brons Breakdown of academic impact, for papers by Francisco Díaz‐Crespo Breakdown of academic impact, for papers by Vesna Júrčić Breakdown of academic impact, for papers by Jeanne Pistillo Breakdown of academic impact, for papers by Boaz Palterer
Rankless by CCL
2026